Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia

Feasibility of high-throughput drug sensitivity screening (HDS)-guided treatment for children with refractory or relapsed acute myeloid leukemia

Relapsed/refractory (rel/ref) acute myeloid leukemia (AML) has a very high mortality rate. At present, hematopoietic stem cell transplantation (HSCT) is the most effective treatment for rel/ref AML. The remission of the primary disease before HSCT is crucial for the transplantation to be effective....

Full description

Bibliographic Details
Main Authors: Wenxiu Lv, Tianping Chen, Shen Wang, Chun Li, Bo Zhang, Liang Wang, Fang Xv, Fang Cao, Jing Wang, Li Chen, Chenglin Liao, Na Li, Hongjun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
pediatric
high-throughput drug sensitivity screening
hematopoietic stem cell transplantation (HCST)
relapsed/refractory
acute myeloid leukemia
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1117988/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1117988/full

Similar Items